[(ButC5H4)2NdMe]2催化聚合甲基丙烯酸甲酯

茂基钕甲基化合物;亲核取代反应;[(ButC5H4)2NdMe]2催化聚合甲基丙烯酸甲酯     

Synthesis and Crystal Structure of 3,3‘—（Hexane—1,6—diyl）bis（1—acetyl—5,5—dimethylhydantoin）,a New Inducer of Differentiation

The title compound C20H30N4O6, Mr = 422.48)was synthesized and its crystal structure was determined by X-ray diffraction method. It crystallizes in the triclinic system, space group P ī with cell parameters: a = 8.330(2), b = 8.468(2), c = 16.017(3) A, α = 97.30(3), β = 92.33(3), γ = 103.94(3)o, V = 1084.7(4) A3, Dc = 1.294 g/cm3, Z = 2, F(000) = 452 and μ = 0.096 mm-1. The structure was refined to R = 0.0483 for 3732 observed reflections with I>2(I) and wR = 0.1335 for 4828 unique reflections. The hydantoin rings are planar and the two ring planes of one molecule are paralleled to each other.     

Syntheses, Structures and Characterizations of Two New Vanadium(V) Complexes: [PyH][VⅤO2(C14H9N2O3Br)] and [VⅤO(C14H9N2O3Br)(OCH3)]

The new oxovanadium (Ⅴ) complex, [PyH][VO2(L)] 1 (salicyladehyde 5-bromo salicyloylhydrazone is abbreviated as H2L; Hpy is protonated pyridine) was obtained from a refluxed solution of VOSO4 and H2L in acetonitrile-methanol-pyridine. Similarly, another new complex, [VO(L)(OCH3)] 2 was synthesized by refluxing VOSO4 and H2L in methanol-pyridine. Crystal data for 1: C19H15N3O5BrV, Mr = 496.2, monoclinic, P21/n, a = 7.1885(3), b = 9.2718(3), c = 28.803(1) (A), ( = 96.185(1)(, Z = 4 and V = 1908.6(1) (A)3; for 2: C15H12N2O5BrV, Mr = 431.1, monoclinic, P21/n, a = 12.202(2), b = 8.045(2), c = 16.604(3)(A), ( = 101.29(3)(, Z = 4 and V = 1598.4(2)(A)3. The structures of 1 and 2 have been determined by X-ray analyses and reveal that the coordination environments of V atoms in both complexes are of square-based pyramid. Three of the four based donor atoms are from the tridentate "ONO" donor ligand while the fourth is one terminal oxygen atom with the V(1)–O(3) distance 1.646(4) (A) for 1 and one -OCH3 group with the V(1)-O(3) distance 1.753(3)(A) for 2. The V(1)-O(4) terminals occupy the axial sites in both cases. The complexes are also characterized by IR and 1H NMR spectroscopies.     

正丁基黄原酸根合镉(Ⅱ)的合成和晶体结构

黄原酸配合物以及它们与各种路易斯碱反应的产物得到广泛的研究犤１～４犦。可溶性的黄原酸碱金属盐广泛用于汞、银、镉等金属的萃取分离犤５～７犦，并且这类盐对于汞中毒具有解毒作用犤８犦。E．D．Zelmon等犤９犦对过渡金属黄原酸配合物的非线性光学性质进行了研究。但迄今为止，对黄原酸镉配合物与路易斯碱的反应与结构研究较少。我们首先合成了一种配位聚合物犤Cd（S２CO－n－C４H９）２犦n晶体，然后利用吡啶与犤Cd（S２CO－n－C４H９）２犦n反应破坏其原有配位聚合物的结构，得到了犤Cd（C５H５N）２（S２CO－n－C４H９）…     

4-氨基-L-赤-生物蝶呤的全合成研究

报道了两种合成4-氨基-L-赤-生物蝶呤(2)的方法：(1)以2-N-1',2'-O-三乙酰基-L-赤-生物蝶呤(3)为原料,经4-O-甲基化、氨解而得2;(2)为4-氨基-L-赤-生物蝶呤(2)的“一锅法”全合成,即通过保护了的5-脱氧-L-阿拉伯糖(9)和2,4,5,6,-四氨基嘧啶缩合,经碘氧化得到二乙酰氨基生物蝶呤(11),11的进一步乙酰化后即可经硅胶柱层析纯化,获得四乙酰基氨基生物蝶呤(12),用NH3-H2O/MeOH皂化12即得2。5-脱氧-L-阿拉伯糖(7)由L-鼠李糖二乙基缩硫醛衍生物(5)制得,这样由5制备2的总收率为17%。     

S-亚基谷胱甘肽对亚油酸过氧化和苯乙烯聚合的抑制作用的研究

研究了S－亚硝基谷胱甘肽（GSNO）对偶氮二异丁腈(AIBN)引发亚油酸过氧化 和苯乙烯聚合的抑制作用。GSNO的抑制作用可能归结为反应中生砀氮氧自由基的抑 制活性。EPR证据表明,含有AIBN和GSNO的DMSO溶液在无氧和50 ℃下,生成了谷胱 甘肽巯基,2－氰基－2－丙基氮氧自由基。     

Rg—HX(Rg=He,Ne;X=F,Cl,Br)分子间势的精确量子化学从头计算研究III.He—HBr

在用非迭代的三重激发项来校正CCSD的CCSD（T）理论水平下，采用aug-cc- pVQZ基函数对He—HBr的分子间势进行了系统的研究。结果表明：He—HBr以线型结 构存在。在极限基的情况下，复合物两种线型极小点结构He—H—Br和He—Br—H势 阱深分别为28.792 cm~(-1)和35.707 cm~(-1)，对应He原子到HBr分子质心的距离 R分别为0.407 nm和0.343 nm。讨论了不同的基函数和理论方法在研究此类弱束缚 态复合物的分子间势时的可靠性及其对结果的影响，同时也给出了热函数的解析形 式。     

W/O型乳胶粒子表面电性的近代测试技术

采取近代表面电学测试技术对乳胶粒子表面电性进行微观测量，取得了一系列反映胶粒表面双电层结构的特征参量，证明表面扩散双电层的存在。为完善W／O型乳胶体系的稳定性理论提供了一定实验依据。     

用ESCA谱仪研究氟共聚物F2314的共聚特性

由不同共聚比的偏二氟乙烯 (ＶＤＦ)和三氟氯乙烯 (ＣＴＦＥ)共聚合而形成的一系列共聚物体系在工业上有着广泛的应用。其中 ,未硫化的ＶＤＦ/ＣＴＦＥ共聚物 (俗称生胶 )常作为粘结剂。其中 ,氯原子只存在于单体ＣＴＦＥ形成的链段中 ,常用氯含量来表征ＶＤＦ/ＣＴＦＥ共聚物中共聚单体的链节比。但也发现氯含量相似的同一类型的ＶＤＦ/ＣＴＦＥ共聚物的溶解性上常存在较大的差异。影响共聚物溶解性的可能因素[1- 3] 为聚合度及共聚特性 ,包括链接方式等。前期的研究表明溶解性能差异较大的共聚物的聚合度没有明显的变化。本文采用ＥＳＣＡ…     

Efficient Debromination of Vicinal α，β—Dibromo Carboxylic Acid Derivatives with the Sm／HOAc System

The α，β vicinal dibrome carboxylic acid and its derivatives were debrominated with Sm/HOAc system to afford the corresponding cinnamic acid and its derivatives in good yields under mild conditions.